https://www.selleckchem.com/pr....oducts/itacnosertib.
24; 95% CI 1.22-1.27, p 0.001) (1-, 3-, and 5-year overall survival rates (R0 77%, 37%, and 25% vs R1 62%, 19%, and 10%). A positive margin predicts a poorer survival than R0 resections regardless of stage and receipt of adjuvant therapy. Several modifiable factors significantly predict the likelihood of R0 resection including neoadjuvant treatment and treatment at Academic/Research Programs. Knowledge about these factors can help guide patient management by offering neoadjuvant treatment modalities at Academic as well as Comm
Like
Comment
Share
